Literature DB >> 35235254

Corrigendum to: Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function.

.   

Abstract

Entities:  

Year:  2022        PMID: 35235254      PMCID: PMC9010260          DOI: 10.1111/cts.13234

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


× No keyword cloud information.
Jason N. Barreto, Joel M. Reid, Carrie A. Thompson, Kristin C. Mara, Andrew D. Rule, Kianoush B. Kashani, Nelson Leung, Thomas R. Larson, Renee M. McGovern, Thomas E. Witzig, and Erin F. Barreto, Clin Transl Sci. 2022;15:105–117. https://doi.org/10.1111/cts.13125 In the published version of Barreto JN, et al. (2022) there was a typo in the article title, ‘Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function’, the word “Prospective” was mis‐spelled as “Propsective.”. This has been corrected in the online version of the paper.
  1 in total

1.  Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function.

Authors:  Jason N Barreto; Joel M Reid; Carrie A Thompson; Kristin C Mara; Andrew D Rule; Kianoush B Kashani; Nelson Leung; Thomas R Larson; Renee M McGovern; Thomas E Witzig; Erin F Barreto
Journal:  Clin Transl Sci       Date:  2021-08-23       Impact factor: 4.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.